Cargando…
Artemisinin Derivatives Stimulate DR5-Specific TRAIL-Induced Apoptosis by Regulating Wildtype P53
SIMPLE SUMMARY: The risk of developing colorectal cancer at a younger age has increased, but current therapies are either risky or limited. We aim to demonstrate that the combination treatment of artemisinin derivatives and TRAIL could be a potential therapy to kill colon cancer cells. We found that...
Autores principales: | Zhou, Xinyu, Zijlstra, Sietske N., Soto-Gamez, Abel, Setroikromo, Rita, Quax, Wim J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563660/ https://www.ncbi.nlm.nih.gov/pubmed/32899699 http://dx.doi.org/10.3390/cancers12092514 |
Ejemplares similares
-
Dihydroartemisinin-Transferrin Adducts Enhance TRAIL-Induced Apoptosis in Triple-Negative Breast Cancer in a P53-Independent and ROS-Dependent Manner
por: Zhou, Xinyu, et al.
Publicado: (2022) -
Histone Deacetylase Inhibitors Sensitize TRAIL-Induced Apoptosis in Colon Cancer Cells
por: Zhang, Baojie, et al.
Publicado: (2019) -
Erratum to: the ER stress inducer DMC enhances TRAIL-induced apoptosis in glioblastoma
por: van Roosmalen, Ingrid AM, et al.
Publicado: (2014) -
The ER stress inducer DMC enhances TRAIL-induced apoptosis in glioblastoma
por: van Roosmalen, Ingrid A M, et al.
Publicado: (2014) -
Death Receptor 5 Displayed on Extracellular Vesicles Decreases TRAIL Sensitivity of Colon Cancer Cells
por: Setroikromo, Rita, et al.
Publicado: (2020)